Astellas Pharma: Recent Corporate Developments and Market Metrics
Astellas Pharma, a Japanese pharmaceutical company based in Tokyo, has made a dividend announcement on June 20. The company’s stock price was reported at 1390.5 JPY as of the last close.
Market Performance Metrics
The company’s stock has experienced a 52-week range of:
- Low: 1243.5 JPY
- High: 1835 JPY
Valuation Metrics
The current market metrics for Astellas Pharma include:
- Price-to-earnings ratio: 47.6871
- Price-to-book ratio: 1.59894